ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial
November 20, 2024 07:55 ET
|
ZyVersa Therapeutics
Stroke-related cardiovascular injury and dysfunction are induced by AIM2 inflammasome activation in the heart, which can be blocked by ZyVersa's IC 100.
Retrieve Medical, Inc. Selected to Exhibit Retrieve Dx(TM) at Vizient Innovative Technology Exchange
June 04, 2024 11:00 ET
|
Retrieve Medical, Inc.
Retrieve Medical, Inc. Selected to Exhibit Retrieve DxTM at Vizient Innovative Technology Exchange
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
April 19, 2024 13:21 ET
|
Retrieve Medical, Inc.
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Update Results Utilizing Retrieve Dx ™ Software
March 22, 2024 08:00 ET
|
Retrieve Medical, Inc.
RETRIEVE MEDICAL HOLDINGS, INC. (RMHI) ANNOUNCES STUDY UPDATE RESULTS UTILIZING RETRIEVE DxTM SOFTWARE
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals
February 26, 2024 09:00 ET
|
Retrieve Medical, Inc.
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals
Retrieve Medical. Inc. Announces Signed Letter of Intent with Louisiana Health System Hospitals
December 18, 2023 09:30 ET
|
Retrieve Medical, Inc.
Retrieve Medical. Inc. Announces Signed Letter of Intent
with Louisiana Health System Hospitals
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Results Utilizing Retrieve Dx™ Software
October 24, 2023 11:16 ET
|
Retrieve Medical, Inc.
STUDY RESULTS UTILIZING RETRIEVE DX SOFTWARE